Evidence map›Paper›PMID 25821062›Full record

ArticleInternational journal of geriatric psychiatry2016

Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions.

Corinne E Fischer, Windsor Kwan-Chun Ting, Colleen P Millikin, Zahinoor Ismail, Tom A Schweizer, Alzheimer Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in International journal of geriatric psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2019
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Neuropsychiatric Symptoms in Mild Cognitive Impairment.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2017
    Review
  18. Cerebral Glucose Metabolism Assessment in Rat Models of Alzheimer's Disease: An 18F-FDG-PET Study.American journal of Alzheimer's disease and other dementias · 2016
    Article
  19. Article
  20. Role of Hybrid Brain Imaging in Neuropsychiatric Disorders.Diagnostics (Basel, Switzerland) · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Corinne E FischerKeenan Research Centre for Biomedical Science, The Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.
Windsor Kwan-Chun TingInstitute of Medical Science, University of Toronto, Toronto, ON, Canada.
Colleen P MillikinDepartment of Clinical Health Psychology, College of Medicine, Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Zahinoor IsmailHotchkiss Brain Institute, Calgary, AB, Canada.
Tom A SchweizerInstitute of Medical Science, University of Toronto, Toronto, ON, Canada.
Alzheimer Disease Neuroimaging Initiative
St. Michael's Hospital · CAManitoba Health · CAOntario Brain Institute · CA

Funding

Project 1U19AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MICHAEL W WEINER · 2016 to 2026
$226.7M
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
RL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Ann C. McKee · 2021 to 2026
$25.6M
CIHRNIA NIH HHS P30 AG013846NIA NIH HHS P30 AG072978NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG024904NIA NIH HHS U24 AG021886
6 · The paper itself

Abstract

objectiveWe conducted a neuroimaging analysis to understand the neuroanatomical correlates of gray matter loss in a group of mild cognitive impairment and early Alzheimer's disease patients who developed delusions.

methodsWith data collected as part of the Alzheimer's Disease Neuroimaging Initiative, we conducted voxel-based morphometry to determine areas of gray matter change in the same Alzheimer's Disease Neuroimaging Initiative participants, before and after they developed delusions.

resultsWe identified 14 voxel clusters with significant gray matter decrease in patient scans post-delusional onset, correcting for multiple comparisons (false discovery rate, p < 0.05). Major areas of difference included the right and left insulae, left precuneus, the right and left cerebellar culmen, the left superior temporal gyrus, the right posterior cingulate, the right thalamus, and the left parahippocampal gyrus.

conclusionsAlthough contrary to our initial predictions of enhanced right frontal atrophy, our preliminary work identifies several neuroanatomical areas, including the cerebellum and left posterior hemisphere, which may be involved in delusional development in these patients.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAtrophyBrain MappingCognitive DysfunctionDelusionsFemaleGray MatterHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleNeuroimagingAlzheimer's diseasedelusionspsychosisvoxel-based morphometry

Identifiers

PMID25821062
PMCPMC5963287
OpenAlexW2118960860

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.